The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection), a radioactive diagnostic agent for prostate cancer detection.

The FDA has granted accelerated approval to Vanrafia to reduce proteinuria in adults with primary IgAN at risk of rapid disease progression.

The Senate has confirmed Dr Jay Bhattacharya as the new director of the NIH and Dr Marty Makary as the new commissioner of the FDA.

Investigators report findings from an analysis of 7836 robotic-assisted radical cystectomies performed from 2010 to 2021.

Radiographic disappearance of metastases could be a surrogate marker for outcomes among patients treated for metastatic ...

Durvalumab plus gemcitabine and cisplatin significantly improved event free survival and overall survival compared with gemcitabine and cisplatin. The Food and Drug Administration (FDA) has ...

Maintaining systolic blood pressure consistently below 130 mmHg could help decrease the risk for new-onset diabetes in the ...

Cretostimogene is an oncolytic immunotherapy with dual mechanism of action: viral replication leading to tumor lysis and release of granulocyte-macrophage colony stimulating factor.

More than 2 decades have passed since I became the first full-time editor of Renal & Urology News. During that time, the ...

Delays in initiating neoadjuvant chemotherapy (NAC) after TURBT for muscle-invasive bladder cancer and in performing radical cystectomy after completing NAC are associated with worse survival ...